dulaglutide vs semaglutide vs tirzepatide Tirzepatide: Which GLP-1 Wins for Weight Loss? Gastro-intestinal" adverse events reported in

DOI:10.1007/s13277-013-0727-x [ Links ] 51

Jenkins SJ, Ruckerl D, Thomas GD et al (2013) IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1

10.1038/nrdp.2017.88 84 RomanoK

Long-term risks include: gallstones chronic gallbladder inflammation need for gallbladder removal (cholecystectomy) recurrent biliary pain Thyroid Tumor Risk (Black Box Warning) Several GLP-1 drugs carry an FDA boxed warning for thyroid C-cell tumors and Medullary Thyroid Carcinoma (MTC), based on long-term rodent studies

We don't yet know: What percentage of dysesthesia cases resolve vs

The Biochemical Journal